These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 12428222)
21. D-penicillamine is not an effective treatment in systemic sclerosis. Furst DE; Clements PJ Scand J Rheumatol; 2001; 30(4):189-91. PubMed ID: 11578010 [TBL] [Abstract][Full Text] [Related]
22. [Treatment of renal crisis in progressive systemic sclerosis with captopril]. Latorre LC; Mion D; Zerbini CA; Pastor EH; Resende C; Fidelis TS; Gabriel Júnior A; Assad RL; Cossermelli W Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):18-21. PubMed ID: 3903950 [No Abstract] [Full Text] [Related]
23. Observational data to study medication outcomes in systemic sclerosis. Hudson M; Baron M; ; Steele R J Rheumatol; 2011 Mar; 38(3):575-7. PubMed ID: 21362793 [No Abstract] [Full Text] [Related]
27. [Case of the development of the nephrotic syndrome in a female patient with systemic scleroderma against a D-penicillamine treatment background]. Grebeneva LS Vopr Revm; 1979; (1):51-3. PubMed ID: 425416 [No Abstract] [Full Text] [Related]
28. Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis. Kahl LE; Medsger TA; Klein I J Rheumatol; 1985 Oct; 12(5):990-1. PubMed ID: 4087275 [TBL] [Abstract][Full Text] [Related]
33. Renal involvement in progressive systemic sclerosis. Jayson MI Proc R Soc Med; 1975 Sep; 68(9):544-5. PubMed ID: 1197333 [No Abstract] [Full Text] [Related]
34. [Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma]. Murav'ev IuV; Aliab'eva AP; Sigidin IaA; Guseva NG; Balabanova RM Ter Arkh; 1985; 57(8):125-7. PubMed ID: 3906994 [No Abstract] [Full Text] [Related]
35. Kidney disease other than renal crisis in patients with diffuse scleroderma. Steen VD; Syzd A; Johnson JP; Greenberg A; Medsger TA J Rheumatol; 2005 Apr; 32(4):649-55. PubMed ID: 15801020 [TBL] [Abstract][Full Text] [Related]
36. Red cell fragmentation preceding a renal crisis in a patient with systemic sclerosis undergoing haematopoietic stem cell transplantation. David S; Englert H; Furlong T; Rainer S; Moore J Bone Marrow Transplant; 2005 Mar; 35(6):629-30. PubMed ID: 15756287 [No Abstract] [Full Text] [Related]
37. Kidney crisis in systemic sclerosis. Lewandowski B; Domysławska I; Klimiuk PA; Sierakowski S Rocz Akad Med Bialymst; 2005; 50 Suppl 1():294-6. PubMed ID: 16119690 [TBL] [Abstract][Full Text] [Related]
38. Systemic sclerosis/scleroderma: a treatable multisystem disease. Hinchcliff M; Varga J Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973 [TBL] [Abstract][Full Text] [Related]
39. Renal manifestations of systemic sclerosis--clinical features and outcome assessment. Denton CP Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v54-6. PubMed ID: 18784147 [TBL] [Abstract][Full Text] [Related]
40. Shifting our thinking about uncommon disease trials: the case of methotrexate in scleroderma. Johnson SR; Feldman BM; Pope JE; Tomlinson GA J Rheumatol; 2009 Feb; 36(2):323-9. PubMed ID: 19040308 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]